Dermatologic Manifestations of Diabetes

Shivani Patel, M.D., Meg Gerstenblith, M.D., Mimi Huizinga, M.D.
Dermatologic Manifestations of Diabetes is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please log in or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

COVID-19 Update with Dr. Paul Auwaerter of Johns Hopkins : Omicron Variant, Testing, and TreatmentCOVID-19 Update with Dr. Paul Auwaerter of Johns Hopkins : Omicron Variant, Testing, and Treatment

Coronavirus COVID-19 (SARS-CoV-2)Coronavirus COVID-19 (SARS-CoV-2)

Suicide Risk in the COVID-19 PandemicSuicide Risk in the COVID-19 Pandemic

Moderna COVID-19 VaccineModerna COVID-19 Vaccine

BNT162b2 COVID-19 Vaccine (BioNTech/Pfizer)BNT162b2 COVID-19 Vaccine (BioNTech/Pfizer)

Managing Stress and Coping with COVID-19Managing Stress and Coping with COVID-19

Johnson & Johnson COVID-19 VaccineJohnson & Johnson COVID-19 Vaccine

-- The first section of this topic is shown below --

DEFINITION

  • Dermatologic manifestations of diabetes are common and vary in clinical presentation[12].
  • Skin findings may help diagnose diabetes (e.g. acanthosis nigricans) or reflect long-term complications of diabetes (e.g. necrobiosis lipoidica diabeticorum [NLD]).
  • The dermatologic manifestations may be due to deposition of advanced glycosylation end-products (AGEs), infection, autoimmune conditions, or related to pharmacological therapy for diabetes (i.e. insulin).
  • Often, skin manifestations reflect other coexisting conditions such as dyslipidemia.

-- To view the remaining sections of this topic, please log in or purchase a subscription --

DEFINITION

  • Dermatologic manifestations of diabetes are common and vary in clinical presentation[12].
  • Skin findings may help diagnose diabetes (e.g. acanthosis nigricans) or reflect long-term complications of diabetes (e.g. necrobiosis lipoidica diabeticorum [NLD]).
  • The dermatologic manifestations may be due to deposition of advanced glycosylation end-products (AGEs), infection, autoimmune conditions, or related to pharmacological therapy for diabetes (i.e. insulin).
  • Often, skin manifestations reflect other coexisting conditions such as dyslipidemia.

There's more to see -- the rest of this entry is available only to subscribers.

© 2000–2022 Unbound Medicine, Inc. All rights reserved